Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766906 · ClinicalTrials.gov registry record · NA
STEM (Science, Technology, Engineering & Math) Familia Talk
A NA study of Language Development, sponsored by Oregon Research Behavioral Intervention Strategies.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03766906: Completed NA study of Language Development, sponsored by Oregon Research Behavioral Intervention Strategies.
NCT03766906 is a NA study of Language Development that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 50 participants, below the 104-participant average among 13 other Language Development trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03766906, a NA study of Language Development, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
After development of the Talk Stem Familia (TSF) smart-speaker application prototype, the study will evaluate the prototype's efficacy in a within-subjects pre-post design study. The sample will contain 50 parent-student/child dyads who will use the Alexa skill app for 6 weeks.
Primary Outcome
The Student Academic Vocabulary Knowledge in English measure includes 18 multiple choice questions on the 18 words taught in the TSF app. The student chooses the correct word meaning from among four (4) possible responses. Students receive one point for each word correctly identified and points are summed across the 18 items. Scores can range from 0-18 and a higher score indicates greater vocabulary knowledge.
Conditions Studied
Interventions
- BEHAVIORAL Talk STEM Familia app
Study Locations (1)
Oregon
- Oregon Research Behavioral Intervention Strategies, Inc. - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT03766906 record still lists
NCT03766906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 104-participant average among 13 other Language Development trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Language Development appearing as the primary indexed condition, and to 1 intervention - of which Talk STEM Familia app is the first listed.
NCT03766906 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03766906 about?
NCT03766906 is a clinical study titled "STEM (Science, Technology, Engineering & Math) Familia Talk". After development of the Talk Stem Familia (TSF) smart-speaker application prototype, the study will evaluate the prototype's efficacy in a within-subjects pre-post design study. The sample will contain 50 parent-student/child dyads who will use the Alexa skill app for 6 weeks.
What is the current status of trial NCT03766906?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-03-01. Estimated completion is 2019-09-30.
What conditions does trial NCT03766906 study?
This clinical trial studies the following conditions: Language Development.
What interventions are being tested in trial NCT03766906?
The interventions under investigation include: Talk STEM Familia app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03766906?
This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03766906 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Language Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03766906's enrollment target sits among peer trials
50 8th of 13 higher than 6 of 13 other Language Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Language Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
-
Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
RECRUITING · NA
-
Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II
RECRUITING · NA
-
Improving Outcomes Using Technology for Children Who Are DHH
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI